Indicators of responsiveness to immune checkpoint inhibitors

Modulation of the immune system can produce anti-tumor responses in various cancer types, including melanoma. Recently, immune checkpoint inhibitors (ICI), in single agent and combination regimens, have produced durable and long-lasting clinical responses in a subset of metastatic melanoma patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Shields, Bradley D., Mahmoud, Fade, Taylor, Erin M., Byrum, Stephanie D., Sengupta, Deepanwita, Koss, Brian, Baldini, Giulia, Ransom, Seth, Cline, Kyle, Mackintosh, Samuel G., Edmondson, Ricky D., Shalin, Sara, Tackett, Alan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429745/
https://www.ncbi.nlm.nih.gov/pubmed/28400597
http://dx.doi.org/10.1038/s41598-017-01000-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429745/
https://www.ncbi.nlm.nih.gov/pubmed/28400597
http://dx.doi.org/10.1038/s41598-017-01000-2

Ejemplares similares